MedPath

3D OCT in Diabetic Macular Edema to Determine Response to Anti-VEGF Drug Therapy

Not Applicable
Recruiting
Conditions
Diabetic Macular Edema
Registration Number
JPRN-UMIN000047797
Lead Sponsor
university of Fukui Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

1. typical focal DME with ring-shaped hard exudate 2. other retinal diseases, such as retinal vein occlusion or uveitis 3. anti-VEGF therapy with focal/grid laser photocoagulation 4. excessively severe medial opacity that precluded fundal evaluation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage decrease in retinal thickness by site at 1 month after treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath